
<!DOCTYPE html>

<html lang="id">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Corneal cross-linking - Situs Pengetahuan</title>
<meta content="Corneal cross-linking (CXL) with riboflavin (vitamin B2) and UV-A light is a surgical treatment for corneal ectasia such as keratoconus, PMD, and post" name="description"/>
<style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 1200px; margin: 0 auto; padding: 20px; }
        .container { display: flex; }
        .content { flex: 3; padding-right: 20px; }
        .sidebar { flex: 1; background: #f5f5f5; padding: 15px; }
        nav { background: #333; padding: 10px; margin-bottom: 20px; }
        nav a { color: white; margin-right: 15px; text-decoration: none; }
        img { max-width: 100%; height: auto; }
        footer { margin-top: 40px; padding-top: 20px; border-top: 1px solid #ddd; }
        .ad-container { margin: 20px 0; text-align: center; }
    </style>
</head>
<body>
<nav>
<a href="https://situsanda.com">Beranda</a>
<a href="https://situsanda.com/kategori.html">Kategori</a>
</nav>
<div class="container">
<div class="content">
<h1>Corneal cross-linking</h1>
<img alt="Corneal cross-linking" src="https://upload.wikimedia.org/wikipedia/commons/9/90/Cross-linking_procedure%2C_UV_light_source.jpg"/>
            
            Corneal cross-linking (CXL) with riboflavin (vitamin B2) and UV-A light is a surgical treatment for corneal ectasia such as keratoconus, PMD, and post-LASIK ectasia.<br/><br/>It is used in an attempt to make the cornea stronger. According to a 2015 Cochrane review, there is insufficient evidence to determine if it is useful in keratoconus. In 2016, the US Food and Drug Administration approved riboflavin ophthalmic solution crosslinking based on three 12-month clinical trials.<br/><br/><br/><br/><br/><br/>== Medical uses ==<br/><br/>A 2015 Cochrane review found that the evidence on corneal cross-linking was insufficient to determine if it is an effective procedure for the treatment of keratoconus.<br/><br/><br/><br/><br/><br/>== Adverse effects ==<br/><br/>Among those with keratoconus who worsen, CXL may be used. In this group, the most common side effects are haziness of the cornea, punctate keratitis, corneal striae, corneal epithelium defect, and eye pain. In those who use it after post-LASIK ectasia, the most common side effects are haziness of the cornea, corneal epithelium defect, corneal striae, dry eye, eye pain, punctate keratitis, and sensitivity to bright lights.<br/><br/>There are no long-term studies about crosslinking effect on pregnancy and lactation. According to a manufacturer crosslinking should not be performed on pregnant women.
        </div>
<div class="sidebar">
<div class="ad-container">
<script type="text/javascript">
                            atOptions = {
                                'key': '0cfd3aa635d270e67b5af101e4d64321',
                                'format': 'iframe',
                                'height': 250,
                                'width': 300,
                                'params': {}
                            };
                        </script>
<script src="//padsims.com/0cfd3aa635d270e67b5af101e4d64321/invoke.js" type="text/javascript"></script>
</div>

<h3>Artikel Terkait</h3>
<ul>
<li><a href="frédéric-hélein.html">Frédéric Hélein</a></li>
<li><a href="reuven-yudalevich.html">Reuven Yudalevich</a></li>
<li><a href="alberto-baldonado.html">Alberto Baldonado</a></li>
<li><a href="gradec,-zagreb.html">Gradec, Zagreb</a></li>
<li><a href="pamela-blake.html">Pamela Blake</a></li>
</ul>
</div>
</div>
<footer>
<p>© 2023 Situs Pengetahuan</p>
</footer>
</body>
</html>